‘The potential here is huge’: Using exosomes to package and deliver drug therapy

exosomes

Millions of tiny bubbles, released from cells and packaged with molecular mail, are racing through your bloodstream right now. And until recently, only a handful of researchers gave them any thought.

Called exosomes, these lipid vesicles shuttle proteins and genetic information between both neighboring and distant cells.

The vesicles are implicated in spreading diseases, including cancer, and metabolic conditions, like diabetes and obesity. A recent study even points to exosomes as a culprit for distributing amyloid-β, the plaque-forming protein that accumulates in the brains of people with Alzheimer’s disease. If exosomes can so easily carry molecules that spread disease, scientists began thinking they might be useful to carry molecules that stop disease.

Related article:  Just one head injury could 'tangle' proteins in the brain, leading to Alzheimer's

In many cases, it is not clear what molecules inside the exosomes have therapeutic properties, but several stem cell companies are pivoting to exosomes nonetheless. For example, Capricor Therapeutics, which was founded in 2005 to develop stem cell therapies derived from heart tissue, is now using exosomes derived from those same cells to try to treat cardiac and inflammatory conditions.

“[T]hey are important in almost every aspect of biology and medicine,” [scientist Stephen] Gould once said. “The potential here is huge.”

Read full, original post: Meet the exosome, the rising star in drug delivery

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Video: Test everyone – Slovakia goes its own way to control COVID

Video: Test everyone – Slovakia goes its own way to control COVID

As Europe sees record coronavirus cases and deaths, Slovakia is testing its entire adult population. WSJ's Drew Hinshaw explains how ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
globalmethanebudget globalcarbonproject cropped x

Infographic: Cows cause climate change? Agriculture scientist says ‘belching bovines’ get too much blame

A recent interview by Caroline Stocks, a UK journalist who writes about food, agriculture and the environment, of air quality ...
organic hillside sweet corn x

Organic v conventional using GMOs: Which is the more sustainable farming?

Many consumers spend more for organic food to avoid genetically modified products in part because they believe that “industrial agriculture” ...
benjamin franklin x

Are most GMO safety studies funded by industry?

The assertion that biotech companies do the research and the government just signs off on it is false ...
favicon

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies for tighter GMO legislation and famously puts out annual "dirty dozen" list of fruits and ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be the prime mover behind the ongoing campaign against agricultural biotechnology at Consumer Reports. He is an ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend